CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 48 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $15,593,000 | +7.0% | 2,147,797 | -4.2% | 0.00% | 0.0% |
Q3 2016 | $14,578,000 | +19.5% | 2,242,700 | +0.4% | 0.00% | 0.0% |
Q2 2016 | $12,197,000 | +2.5% | 2,233,885 | -12.2% | 0.00% | 0.0% |
Q1 2016 | $11,904,000 | -6.2% | 2,543,547 | -0.2% | 0.00% | 0.0% |
Q4 2015 | $12,689,000 | +36.7% | 2,547,894 | +3.2% | 0.00% | 0.0% |
Q3 2015 | $9,279,000 | -37.9% | 2,467,793 | -0.7% | 0.00% | 0.0% |
Q2 2015 | $14,933,000 | +9.5% | 2,484,644 | +2.0% | 0.00% | 0.0% |
Q1 2015 | $13,640,000 | +90.1% | 2,435,646 | +1.8% | 0.00% | +100.0% |
Q4 2014 | $7,176,000 | +12.1% | 2,392,123 | +0.1% | 0.00% | 0.0% |
Q3 2014 | $6,404,000 | -1.9% | 2,389,631 | +2.5% | 0.00% | 0.0% |
Q2 2014 | $6,526,000 | -35.6% | 2,330,742 | +0.3% | 0.00% | -50.0% |
Q1 2014 | $10,135,000 | +46.8% | 2,324,499 | +8.1% | 0.00% | +100.0% |
Q4 2013 | $6,903,000 | +107.2% | 2,150,366 | +2.6% | 0.00% | 0.0% |
Q3 2013 | $3,332,000 | -8.0% | 2,095,507 | +0.1% | 0.00% | 0.0% |
Q2 2013 | $3,623,000 | – | 2,094,244 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,188,417 | $85,349,000 | 7.80% |
TANAKA CAPITAL MANAGEMENT INC | 144,602 | $2,379,000 | 5.69% |
INGALLS & SNYDER LLC | 6,817,540 | $112,149,000 | 5.47% |
NEXTHERA CAPITAL LP | 1,045,196 | $17,193,000 | 2.83% |
Timpani Capital Management LLC | 245,279 | $4,035,000 | 1.41% |
S&T BANK/PA | 426,257 | $7,012,000 | 1.25% |
SHAKER INVESTMENTS LLC/OH | 107,670 | $1,771,000 | 1.10% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 434,624 | $7,150,000 | 0.94% |
AMI ASSET MANAGEMENT CORP | 709,300 | $11,668,000 | 0.83% |
Birchview Capital, LP | 75,500 | $1,242,000 | 0.82% |